3'(2'), 5'-Bisphosphate Nucleotidase 1 (BPNT1) Peptide
Quick Overview for 3'(2'), 5'-Bisphosphate Nucleotidase 1 (BPNT1) Peptide (ABIN937539)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- DRVTIQELTA PLLTTAQAKP GETQEEETNS GEEPFIETPR QDGVSRRFIP
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of BPNT1 antibody,
Alternative Names: BPNT1 control peptide, BPNT1 antibody Blocking Peptide, Anti-BPNT1 Blocking Peptide, 3' 2' 5'-bisphosphate nucleotidase 1 Blocking Peptide, 2', 5'-Bisphosphate Nucleotidase 1 Blocking Peptide, PIP Blocking Peptide, BPNT1, BPNT-1, BPNT 1, BPNT-1 Blocking Peptide, BPNT 1 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- BPNT1 (3'(2'), 5'-Bisphosphate Nucleotidase 1 (BPNT1))
-
Background
- BPNT1, also called bisphosphate 3-prime-nucleotidase, or BPntase, is a member of a magnesium-dependent phosphomonoesterase family. Lithium, a major drug used to treat manic depression, acts as an uncompetitive inhibitor of BPntase. The predicted human protein is 92 % identical to mouse BPntase. BPntase's physiologic role in nucleotide metabolism may be regulated by inositol signaling pathways. The inhibition of human BPntase may account for lithium-induced nephrotoxicity.
-
Molecular Weight
- 29 kDa
Target
-